Saravanakumar Sundararajan

Statistics

Publications

Citations

143

H-Index

Active since

2017

Affiliations

Madras Diabetes Research Foundation(Current)

Dr. Mohan's Diabetes Specialities Centre

Saravanakumar Sundararajan is an author at Madras Diabetes Research Foundation specializing in cell signaling, insulin resistance, and diabetes mellitus.

ORCID

Publications per year

2017–2021

Publications

Sestrin2 regulates monocyte activation through AMPK‐mTOR nexus under high‐glucose and dyslipidemic conditions

Saravanakumar Sundararajan, Isaivani Jayachandran, Muthuswamy Balasubramanyam et al. · Journal of Cellular Biochemistry · 2018 · 47 citations

Life Sciences, Biochemistry, Cell Biology +17

Decreased Sestrin levels in patients with type 2 diabetes and dyslipidemia and their association with the severity of atherogenic index

Saravanakumar Sundararajan, Isaivani Jayachandran, Savitha Subramanian et al. · Journal of Endocrinological Investigation · 2020 · 29 citations

Medicine, Endocrinology, Diabetology +13

Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway

Isaivani Jayachandran, Saravanakumar Sundararajan, S. Venkatesan et al. · Scientific Reports · 2020 · 27 citations · Full text

Medicine, Pathology, Pharmacology +17

Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury

Isaivani Jayachandran, Saravanakumar Sundararajan, Prabu Paramasivam et al. · Clinical Biochemistry · 2017 · 20 citations

Medicine, Molecular Medicine, Nephrology +13

Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin

Kuppan Gokulakrishnan, Gautam Kumar Pandey, Sathishkumar Chandrakumar et al. · Molecular Biology Reports · 2021 · 20 citations

Life Sciences, Endocrinology, Pharmacology +12

1–5 of 5